Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × INDIV × Clear all

Phase

Phase 2 13 Phase NA 7 Phase EARLY_PHASE1 4 Phase 4 4 Phase 1 3 Phase 1/2 2 Phase 3 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 815 INDUSTRY 296 NIH 37 OTHER_GOV 28 NETWORK 27 FED 7 UNKNOWN 5 INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡